Pellepharm Is A Biotechnology Company Committed To Targeting Rare Dermatologic Diseasesincluding Gorlin Syndrome And High Frequency Basal Cell Carcinomasbccs At Their Sourcefounded By World Leaders In Hedgehog Signalingpellepharm Is Working To Improve The Quality Of Life For Those Suffering From Regulardebilitating Surgeries By Providing An Easy To Use Topical Solution That Eliminates This Need And Provides An Overall Better Quality Of Life The Standard Of Care For These Diseases Is Surgeryin Particularpeople With Severe Gorlin Syndrome May Have As Many As 30 Surgeries Per Yearwhich Can Be Repetitive And Scarring Pellepharm S Patidegib Gel Has Shown Early Promise In A Phase 2 Clinical Study For The Mitigation Of The Bcc Tumors In Gorlin Syndrome By Blocking The Disease At Its Source Within The Hedgehog Signaling Pathwaybecause Oral Formulations For This Treatment Typically Have Serious Systemic Side Effects Which Cause Many Patients To Discontinue Treatmentpatidegib Is Formulated As A Topical Gel To Reduce Its Side Effect Profile Due To Its Minimal Systemic Exposure Pellepharm Is Located In San Franciscocalifornia For More Information About Pellepharmplease Visit Us At Www Pellepharm Com
No conferences found for this company.
| Company Name | Pellepharm Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
